Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis

ConclusionsThese data suggest colchicine, in addition to guideline-directed medical therapy following acute coronary syndrome reduces MACE, cerebrovascular accidents, and rates of urgent revascularization at 2 years of follow-up.

Source: Cardiology and Therapy - January 6, 2023 Category: Cardiology Source Type: research